Prevalence and predictors of the sub-target Hb level in children on dialysis

Nephrol Dial Transplant. 2012 Oct;27(10):3950-7. doi: 10.1093/ndt/gfs178. Epub 2012 Jun 27.


Background: Anaemia is a common and potentially treatable co-morbidity of end-stage renal disease. We aimed to determine the prevalence of the sub-target haemoglobin (Hb) level among European children on dialysis and to identify factors associated with a low Hb level.

Methods: From the European Society for Paediatric Nephrology (ESPN)/European Renal Association-European Dialysis Transplant Association (ERA-EDTA) registry, data were available on 2351 children between 1 month and 18 years of age, totalling 5546 measurements from 19 countries.

Results: The mean Hb level was 10.8 g/dL (5th-95th percentiles, 7.4-13.9). Among those above 2 years of age, the mean Hb level was 10.9 g/dL (11.4% below 8.5 g/dL), while it was 10.3 g/dL among those below 2 years (11.2% below 8.0 g/dL). A total of 91.2% of the patients were on an erythropoiesis-stimulating agent (ESA). Hb levels increased with age and were higher in peritoneal dialysis compared with haemodialysis patients. Patients with congenital anomalies of the kidney and urinary tract showed the highest Hb levels, and those with cystic kidney diseases or metabolic disorders the lowest ones. Ferritin levels between 25 and 50 ng/mL were associated with the highest Hb levels. We found a weak inverse association between parathyroid hormone (PTH) and Hb. Whereas standardized blood pressure (BP) was not elevated in patients with above-target Hb, elevated systolic BP z-score was noted in those with sub-target Hb levels.

Conclusions: Sub-target Hb levels remain common in children on dialysis, in spite of virtually all children being treated with ESA; although we cannot exclude under-dosing. Optimal ferritin levels seemed to be slightly lower in children (25-50 ng/mL) than those in adults. Other risk factors for sub-target Hb are dialysis modality and a high PTH level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Anemia / blood
  • Anemia / etiology
  • Anemia / therapy
  • Blood Pressure
  • Body Height
  • Child
  • Child, Preschool
  • Europe
  • Female
  • Ferritins / metabolism
  • Hematinics / therapeutic use
  • Hemoglobins / metabolism*
  • Humans
  • Infant
  • Iron / therapeutic use
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / pathology
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Male
  • Parathyroid Hormone / blood
  • Registries
  • Renal Replacement Therapy*
  • Serum Albumin / metabolism


  • Hematinics
  • Hemoglobins
  • Parathyroid Hormone
  • Serum Albumin
  • Ferritins
  • Iron